Prosecution Insights
Last updated: November 20, 2026
Application No. 18/659,920

METHOD AND APPARATUSES FOR ACCESSING AND/OR MODIFYING A TARGET PATIENT TISSUE SITE

Final Rejection §112
Filed
May 09, 2024
Priority
Oct 14, 2016 — provisional 62/408,312 +5 more
Examiner
JAFFRI, ZEHRA
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
The Cleveland Clinic Foundation
OA Round
2 (Final)
58%
Grant Probability
Moderate
3-4
OA Rounds
10m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
52 granted / 90 resolved
-12.2% vs TC avg
Strong +50% interview lift
Without
With
+50.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
42 currently pending
Career history
157
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
44.9%
+4.9% vs TC avg
§102
26.3%
-13.7% vs TC avg
§112
23.0%
-17.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 90 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment In light of Applicant’s amendment, claim(s) 1 and 15 is/are amended. Claims 16-17 remain withdrawn and claims 18-20 are canceled. Claims 1-15 are now pending examination. The rejection(s) under 35 U.S.C. 112(b) to claim(s) 1 regarding the limitation “a shaft delivery element” is/are withdrawn in light of Applicant’s amendment. Response to Arguments Applicant's arguments filed 8/22/2026 have been fully considered but they are not persuasive. In response to the rejection under 35 U.S.C. 112(b) to claim 1 regarding the limitation “implant delivery element”, Applicant’s arguments attempt to place on record the structure of the implant delivery element, as “an implant delivery element” invokes 35 U.S.C. 112(f). However, the written description and Applicant’s Remarks fail to disclose the corresponding structure, material, or acts for performing the entire claimed function and to clearly link the structure, material, or acts to the function. The specification discloses the implant delivery element as 58102 and states “The shaft distal end 5896 has an implant delivery element 58102. The implant delivery element 58102 of the shaft A 5892 has an implant delivery element outer surface 58104 for selectively circumferentially mounting an expandable implant M thereon” (Paragraph 00170). However, there is no structure disclosed, aside from the fact that the implant delivery element has an outer surface. Further, it is not clear as to how the implant delivery element outer surface differs from the outer surface of the distal end, as 5896, 58102, and 58104 seemingly point to the same structure. Applicant argues that arrow 5896 is used to indicate the shaft distal end and leader line 58102 is used to indicate the implant delivery element. However, leader line of component 58102 is pointing to the distal end with no distinctive feature, thus it seems to be the distal end of the shaft. As such it is unclear since the distal end of the shaft is disclosed as a separate component. Additionally, there is no detail shown of the implant delivery element in particular. Further, although the distal end can include more than the implant delivery element, since the scope and structure of the implant delivery element is unclear, it is unclear as to how to distinguish the element from the distal end. Thus, the lack of clarity of the structure of the implant delivery element renders the issues of indefiniteness. Lastly, Applicant argues, “one of ordinary skill in the art would be well aware that a stent or other expandable implant M could be placed (e.g., crimped or otherwise maintained in a collapsed state) about the implant delivery element outer surface 58104 and prevented from longitudinal movement with respect to the implant delivery element 58102 by at least one radially extending projection 58106, which "blocks" unwanted longitudinal motion which otherwise could occur as the expandable element is moved through the vasculature of the patient”. Examiner agrees that one of ordinary skill in the art could be aware of such a function, but the disclosure does not provide an understanding of “an implant delivery element” and such a term is not known in the art. Thus, the rejection is maintained. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: “an outer sheath delivery element”, “a shaft delivery element” and “an implant delivery element” in claim 1. Claim 1 recites the limitation of “an outer sheath delivery element”. The term “element” is used as a substitute for “means” and is modified by functional language “outer sheath delivery”. There is no corresponding structure in the claim, therefore invoking 112(f). Based on the specification, the corresponding structure for “an outer sheath delivery element” is “a stiff wire” (Paragraph 00155) or equivalents thereof. Claim 1 recites the limitation of a “an implant delivery element”. The term “element” is used as a substitute for “means” and is modified by functional language “implant delivery”. There is no corresponding structure in the claim, therefore invoking 112(f). Further, there is no corresponding structure in the specification, aside from being labeled as 58102, therefore the scope of the limitation is indefinite. Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim limitation “an implant delivery element” invokes 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. However, the written description fails to disclose the corresponding structure, material, or acts for performing the entire claimed function and to clearly link the structure, material, or acts to the function. The specification discloses the implant delivery element as 58102 and states “The shaft distal end 5896 has an implant delivery element 58102. The implant delivery element 58102 of the shaft A 5892 has an implant delivery element outer surface 58104 for selectively circumferentially mounting an expandable implant M thereon” (Paragraph 00170). However, there isn’t a structure disclosed, aside from the fact that it has an outer surface. Further, the drawings do point to component 58102, which seems to be the distal end of the shaft, which is unclear as the distal end of the shaft is disclosed as a separate component. Additionally, it is unclear as to the structure of the element based on the drawings, since there is no detail shown. Therefore, the claim is indefinite and is rejected under 35 U.S.C. 112(b) or pre-AIA 35 U.S.C. 112, second paragraph. Applicant may: (a) Amend the claim so that the claim limitation will no longer be interpreted as a limitation under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph; (b) Amend the written description of the specification such that it expressly recites what structure, material, or acts perform the entire claimed function, without introducing any new matter (35 U.S.C. 132(a)); or (c) Amend the written description of the specification such that it clearly links the structure, material, or acts disclosed therein to the function recited in the claim, without introducing any new matter (35 U.S.C. 132(a)). If applicant is of the opinion that the written description of the specification already implicitly or inherently discloses the corresponding structure, material, or acts and clearly links them to the function so that one of ordinary skill in the art would recognize what structure, material, or acts perform the claimed function, applicant should clarify the record by either: (a) Amending the written description of the specification such that it expressly recites the corresponding structure, material, or acts for performing the claimed function and clearly links or associates the structure, material, or acts to the claimed function, without introducing any new matter (35 U.S.C. 132(a)); or (b) Stating on the record what the corresponding structure, material, or acts, which are implicitly or inherently set forth in the written description of the specification, perform the claimed function. For more information, see 37 CFR 1.75(d) and MPEP §§ 608.01(o) and 2181. Claims 2-15 are rejected due to their dependence on claim 1. Due to the 112(b) issues, the scope of the claim could not be determined for the application of prior art. Examiner would advise deleting the claim limitations involving the implant delivery element to ensure a full examination on the merits. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Pilarski et al. (US 20100179561 A1) (previously made of record) discloses a lead delivery system, comprising: an outer jacket (800) having a proximal end and distal end, (Paragraph 0046), the outer jacket distal end having an implant holding pod (distal half of 800) (Paragraph 0046), the implant holding pod having an implant holding pod proximal end and an implant holding pod distal end, the implant holding pod proximal end having an implant holding pod proximal opening, the implant holding pod distal end having an implant holding pod open tip, the implant holding pod having an implant holding pod outer surface and an implant holding pod lumen, the implant holding pod lumen extending between the implant holding pod proximal opening and the implant holding pod open tip, the implant holding pod lumen for selectively holding an implant therein, the implant holding pod having an implant holding pod open slit (820), the implant holding pod open slit extending at least partially between the implant holding pod open tip and the implant holding pod proximal end; and a tool (500) having a proximal end (501), a distal end (502), and a body (510) longitudinally extending between the proximal and distal ends (Figure 8A-B; Paragraph 0039), the body having an open slit (520) (Figure 8C; Paragraph 0039); wherein when the tool is operably joined to the outer jacket, at least a portion of the open slit is selectively laterally spaced from the implant holding pod open slit (Figure 16B; Paragraph 0046). THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ZEHRA JAFFRI whose telephone number is (571)272-7738. The examiner can normally be reached 8 AM-5:30 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, DARWIN EREZO can be reached at (571) 272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Z.J./Examiner, Art Unit 3771 /KATHERINE H MENDEZ/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

May 09, 2024
Application Filed
May 29, 2026
Non-Final Rejection mailed — §112
Aug 22, 2026
Response Filed
Nov 02, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12773205
RUNNING STITCH SUTURING INSTRUMENT
3y 0m to grant Granted Oct 27, 2026
Patent 12740809
ROBOTICALLY CONTROLLED UTERINE MANIPULATOR
5y 0m to grant Granted Sep 22, 2026
Patent 12734033
AORTIC VALVE REPLACEMENT
4y 10m to grant Granted Sep 15, 2026
Patent 12714605
SYSTEMS AND METHODS OF TYMPANOSTOMY TUBE DELIVERY
3y 5m to grant Granted Aug 25, 2026
Patent 12702440
ANCHORED GUIDE TUBES FOR INSERTION AND STABILIZATION OF DEVICES IN BODY WALL, SYSTEMS, AND METHODS
5y 1m to grant Granted Aug 11, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
58%
Grant Probability
99%
With Interview (+50.3%)
3y 4m (~10m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 90 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month